ArticleCureus2026
Evolving Surgical Timing for Bilateral Hip Arthroscopy in Femoroacetabular Impingement: A Comparison of Clinical Outcomes Between Simultaneous and Staged Approaches.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aim Femoroacetabular impingement (FAI) commonly presents with radiographic signs in both hips, and many patients report symptoms on both sides. Hip arthroscopy is the preferred surgical treatment for symptomatic FAI. The optimal approach with the lowest procedural risk between simultaneous and staged bilateral arthroscopy remains debated in the literature. The objective of this single-center study was to compare clinical outcomes, complication rates, length of hospital stay, return to sport, and patient satisfaction among patients undergoing single-stage, early-stage, and two-stage bilateral hip arthroscopy for femoroacetabular impingement. Materials and methods This monocentric retrospective study evaluated patients undergoing bilateral hip arthroscopy for symptomatic FAI between 2017 and 2023, all performed by a single surgeon. Patients were divided into the following three groups: two-stage (TS; ≥6 weeks between procedures), early-stage (ES; second procedure the day after the first), and single-stage (SS; simultaneous) groups. The group assignment was based on shared decision-making, and propensity score matching was used to balance for age, gender, and BMI. Hip Outcome Score - Activities of Daily Life (HOS-ADL), Hip Outcome Score - Sports Subscale (HOS-Sport), International Hip Outcome Tool-12 (iHOT-12), and visual analog scale (VAS) were collected preoperatively and at two years postoperatively. Major complications, return to sport, and patient satisfaction were also recorded. Results The study included 60 TS, 30 ES, and 30 SS patients. Mean cumulative surgical times did not significantly differ between groups. No major complications, revisions, or conversions to total hip replacement were recorded at the two-year follow-up. The total length of hospital stay was significantly shorter in the SS group compared to the TS and ES groups. All clinical outcome scores improved significantly at follow-up. No significant differences were found in HOS, HOS-Sport, iHOT-12, VAS, return to sport, or satisfaction rates between the three groups. Conclusion There is no inferiority in clinical outcomes when using a simultaneous approach compared to more staged approaches. The single-stage group had a significantly shorter mean total length of hospital stay compared to the staged groups. The single-stage approach is a viable solution for selected patients and experienced surgical teams, allowing for outcomes that are not inferior to the early-stage or two-stage approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.